Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $240
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Hamza Fodderwala maintains an Overweight rating on NICE (NASDAQ:NICE) but lowers the price target from $290 to $240.
June 14, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley analyst Hamza Fodderwala maintains an Overweight rating on NICE but lowers the price target from $290 to $240.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some concerns or adjustments in valuation. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100